IntroductIon: Presence of air in mediastinal space, retroperitoneal space or subcutaneously is a rare con-
IntroductIon
A presence of free air in mediastinal space (pneumomediastinum) and in retroperitoneal space (pneumoretroperitoneum) can manifest as tachycardia and chest pain and may need prompt diagnostics and treatment. Trauma, foreign bodies and drug intoxication are some of the potential causes of these phenomena (Tab. 1, Tab. 2). The latter one most frequently occur in young individuals, especially males [1] . Among vast variety of drugs that can lead to SPM (spontaneous pneumomediastinum) stimulants, drugs such as cocaine are usually responsible www.journals.viamedica.pl [2] [3] . Mephedrone (4-methylmethcathinone) is relatively new synthetic cathinone common in recreational use [4] . It has stimulating effect similar to amphetamine (and derivatives) and cocaine. In this report we present a case of pneumomediastinum and pneumoretroperitoneum caused by mephedrone inhalation.
cAse presentAtIon 27-years old male was admitted to emergency department with agitation and impaired verbal and logical contact, tachycardia and tachypnoea, throat ache and high body temperature (39.5°C). Subcutaneous emphysema of neck and chest was noted upon physical examination (Fig. 1A) . The following vital signs and laboratory results were recorded: heart rate 78 bpm, blood pressure 140/60, CRP 186, elevated PCT and glucose level. Empirical antibiotic therapy (ceftriaxone + clarithromycin, fluconazole) was administered and later changed to piperacillin/tazobactam + metronidazole due to suspicion of GI perforation. Diagnostics were extended by neck, chest and abdomen contrast enhanced CT. Pneumomediastinum ( Fig. 2A ) and free air in both peritoneum and retroperitoneum were revealed (Fig.  3A) . Police report stated that patient was using unknown drugs for past 4 days.
InvestIgAtIon
Gastroscopy and bronchoscopy were performed to exclude the possible GI and airway perforation, however, no abnormalities were found. Initially, at admission, patient experienced delusions (i.e. delusions of reference, he believed that medical staff is working for the police). Normal verbal and logical contact was regained after 24 hours. After the patient regained full consciousness detailed interview was possible -patient admitted to inhaling mephedrone.
treAtment
The patient was treated medically. Antibiotic therapy and fluids were maintained during following 5 days of hospital stay. On the last day of hospitalization, a control CT of neck, chest, abdomen and pelvis was performed. The amount of free gas decreased in all locations ( Fig.1-3B ).
follow-up And outcomes
Patient was discharged in good condition after 6 days. No adverse and unanticipated events were observed. Patient was not present on follow-up visits.
dIscussIon
Pneumomediastinum, pneumoretroperitoneum and subcutaneous emphysema may be symptoms of either GI tract or airway perforation. These conditions are potentially life threatening and may need surgical intervention. However, as presented in this case they also may be rare and self-limiting complications of drugs inhalation, which can be treated medically under precise surveillance. Patients seeking aid in emergency department because of SPM were usually admitted with sudden chest pain and dyspnea. Upon exclusion of tension pneumothorax, these symptoms require performing diagnostics to elucidate the reason for presence of free air in and outside of body cavities. As mentioned before GI tract and airway perforation are some of differential diagnoses and may need surgical intervention or fIgure 1. CT scan showing subcutaneous emphysema of neck -at diagnosis (A) and (B) before discharge fIgure 2. CT scan showing pneumomediastinum -at diagnosis (A) and (B) before discharge chest drainage. Bronchoscopy, gastroscopy, colonoscopy and computed tomography can potentially exclude these pathologies. Once these diagnoses are excluded SPM may be diagnosed. Drugs, including cocaine, met(amphetamine), MDMA, marihuana and, as presented, mephedrone may cause SPM and consequently pneumomediastinum and subcutaneous emphysema [5, 6, 7, 8] . Probable explanation of development SPM as a result of inhalable drug use is that overly distended alveoli rupture under high pressure. Whenever the pressure gradient between the alveoli and the surrounding interstitial space is sufficient the free air then dissects from the ruptured alveoli along the bronchovascular sheaths toward the mediastinum, to produce SPM. This sequence of events is known as the "Macklin effect" which is a result of Valsava's maneuver [9] . Similar effect to Valsalva's maneuver occurs in Muller's maneuver in which chest pressure decreases in perialveolar spaces, and as a consequence, air moves to hypothetic perialveolar space, without penetration of pleura [10] . Furthermore, most probable mechanism of pneumoretroperitoneum occurrence is a translocation of free air form the chest to abdomen by aortic hiatus of the diaphragm. Subcutaneous emphysema is a rare condition that presents as a smooth bulging of the skin with a characteristic palpable crepitation. This can be traumatic, iatrogenic (puncture of the respiratory or GI tract) or spontaneous [11] . It can occur anywhere in the body but it is the most common in the head and neck region due to the proximity of the airways. Subcutaneous emphysema is not inherently life threatening and the air will be resorbed over time, but it can be uncomfortable for the patient.
Mephedrone (4-methylmethcathinone) is a relatively novel drug, with first reports of use from 2007. Since then, its use is increasing, especially in Europe [12] . It is a synthetic cathinone that has never been licensed as a medicine and no other legitimate uses are known. The effects and the mode of use have similarities with (meth)amphetamine, cocaine and 3,4-methylenedioxymethylamphetamine (MDMA), but its potency is lesser than (meth) amphetamine [4] . Mephedrone can be administered via oral route, nasal insufflation, intramuscular injection, intravenous injection and rectal insertion. The predominant routes are oral ingestion and nasal insufflation [12] . The most common clinical features concerning mephedrone use are agitation, aggression, tachycardia, anxiety, confusion, psychosis and chest pain, however, it may also have no symptoms [2, 3] . Our patient presented majority of mentioned symptoms including rare ones such as SPM and retroperitoneum.
Most challenging obstacle in this case was the lack of knowledge on the type of substance that the patient was using. Impaired logical contact along with the fact that mephedrone does not come positive on the standard tox-screen delayed precise diagnosis. However, this was not crucial for the treatment, as endoscopic and radiologic examinations confirmed SPM and along with good general condition enabled medical treatment. 
